Epworth Richmond is the first hospital in Australia to introduce an innovative compact probe designed to assist cardiologists in detecting heart valve abnormalities, blood clots, and minor heart defects.
The mini 3D probe, measuring just 11mm wide, is approximately 35% smaller than traditional devices, and suitable for both paediatric and elderly patients. The tiny device, which is gently introduced down the throat, replaces the larger devices currently in use.
Epworth HealthCare is Australia's first hospital group to routinely use the device in cardiac procedures. The first procedure was undertaken using a prototype, and from this month, the procedure will become routinely available.
Epworth cardiologist Dr Chris Anthony is the first specialist to use the mini probe in Australia.
He says having a precise, 3D view is crucial in planning and executing valve repair procedures, with the mini 3D probe most suitable for elderly and frail patients, who may be more susceptible to complications from existing technology.
This represents a significant advancement, shifting from a large sensor to a small, high-definition 3D sensor, enabling a clear view of the heart, while ensuring greater comfort for patients.
"Typically, these procedures can last between two to four hours. Previously, patients required sedation and often had to remain in hospital overnight. We anticipate that the new device will reduce the need for any form of sedation, transforming this procedure into a quicker, more routine day procedure," Dr Anthony said.
This development marks a substantial advancement in interventional cardiac procedures and represents a significant breakthrough in medical technology.
